Who owns Generex Biotechnology Corporation?
Key information on Generex Biotechnology Corporation (Ticker: GNBT)
- CUSIP: 371485103
Who owns Generex Biotechnology Corporation?
Is GNBT a good stock to own? Find out who bought Generex Biotechnology Corporation, who sold Generex Biotechnology Corporation (GNBT) stock, and who holds a large position in Generex Biotechnology Corporation.
- United Capital Financial Advisers owns 184000 shares worth $27600
- Oxbow Advisors owns 10400 shares worth $0
- Herndon Plant Oakley owns 10400 shares worth $1040
- Argyle Capital Management owns 10000 shares worth $0
- E E Geduld owns 10000 shares worth $1000
Who sold Generex Biotechnology Corporation?
- Ameriprise Financial sold on March 31, 2011
- Bascom Hill Partners sold on Dec. 31, 2010
- SummitAlliance Capital Management sold on Dec. 31, 2010
- Tradeworx sold on March 31, 2010
- Zebra Capital Management sold on Dec. 31, 2007
Funds that own GNBT also own:
- Microsoft Corporation (MSFT)
- Coca-Cola Company (KO)
- Exxon Mobil Corporation (XOM)
- Abbott Laboratories (ABT)
- Johnson & Johnson (JNJ)
- Pfizer (PFE)
- Teva Pharmaceutical Industries (TEVA)
- Chevron Corporation (CVX)
- General Electric Company (GE)
- Bristol Myers Squibb (BMY)
- 3M Company (MMM)
- AT&T; (T)
- Cisco Systems (CSCO)
- Kimberly-Clark Corporation (KMB)
- Intel Corporation (INTC)
- Verizon Communications (VZ)
- International Business Machines (IBM)
- Philip Morris International (PM)
- Procter & Gamble Company (PG)
- Oracle Corporation (ORCL)
- Kinder Morgan Energy Partners (KMP)